The expression of miR-21-5p, considered a biomarker of atherosclerotic changes in blood vessels, was correlated with the expression of visfatin—an adipokine responsible, inter alia, for the regulation of glucose metabolism in patients with acute coronary syndrome [34]. The gene discussed is NAMPT; the disease is acute coronary syndrome.